[
    [
        {
            "time": "2019-03-14",
            "original_text": "After Hours Most Active for Mar 14, 2019: GCP, LLY, HPQ, F, PFE, ACB",
            "features": {
                "keywords": [
                    "after hours",
                    "most active",
                    "GCP",
                    "LLY",
                    "HPQ",
                    "F",
                    "PFE",
                    "ACB"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "various"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "After Hours Most Active for Mar 14, 2019: GCP, LLY, HPQ, F, PFE, ACB",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        },
        {
            "time": "2019-03-14",
            "original_text": "Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades",
            "features": {
                "keywords": [
                    "blue chip",
                    "drug stocks",
                    "reckoning",
                    "downgrades"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]